ENDPOINTS

Cytokinetics' stock drops after heart drug PDUFA pushed back due to lack of REMS

Cytokinetics said late Thursday that the PDUFA date for its heart disease therapy aficamten would be delayed by three months to December 26. The lag is to allow the FDA to ...

May 2, 2025 - 11:22
 0
Cytokinetics' stock drops after heart drug PDUFA pushed back due to lack of REMS
Cytokinetics said late Thursday that the PDUFA date for its heart disease therapy aficamten would be delayed by three months to December 26. The lag is to allow the FDA to ...
Read More

Tags:

Previous Article

Searching for dark photons in the Sun’s atmosphere

Next Article

Electrosynthesis of urea from flue gas achieves high efficiency with no ammonia ...

Related Posts

Alis Biosciences to press struggling biotechs during downturn

Alis Biosciences to press struggling biotechs during do...

Apr 25, 2025  0

Summit, Akeso report another Phase 3 win for PD-1xVEGF approach in lung cancer

Summit, Akeso report another Phase 3 win for PD-1xVEGF ...

Apr 23, 2025  0

AstraZeneca rejoins PhRMA, two years after leaving lobby group

AstraZeneca rejoins PhRMA, two years after leaving lobb...

Apr 22, 2025  0